Recent developments in protein kinase C inhibitors

Expert Opinion on Therapeutic Patents

Volumn 7, Issue 1, 1997, Pages 63-68

  Harris, W ^a   Wilkinson, S E ^a   Nixon, J S ^a  

^a ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; 7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BISINDOLYLMALEIMIDE; CARBAZOLE DERIVATIVE; D 21621; DOXORUBICIN; ISIS 3521; ISOENZYME; MITOMYCIN C; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; STAUROSPORINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PATENT; REVIEW;

EID: 0030864058     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.7.1.63     Document Type: Review

References (17)